Faslodex (chemical name: fulvestrant) is approved by the U.S. Food and Drug Administration to treat:
Faslodex is only ERD available to treat breast cancer.
Faslodex won't work on hormone-receptor-negative breast cancer.
Faslodex is liquid that is given once a month as an injection into a muscle, usually at your doctor's office. Women usually get Faslodex as long as it is effectively treating the cancer.
Research has shown that Faslodex works as well as or better than Arimidex (chemical name: anastrozole), an aromatase inhibitor, in slowing or stopping the growth of metastatic (breast cancer that has spread to other parts of the body), hormone-receptor-positive breast cancer in post-menopausal women after tamoxifen has stopped working.
The most common side effects of Faslodex are:
Some women may have the following side effects while getting Faslodex:
Costs for Faslodex can vary. If you have health insurance, check with your insurance company to see if and how much of the cost of Faslodex is covered. If you don't have health insurance or your insurance doesn't cover the cost of Faslodex, ask your doctor or nurse about programs in your area that may be able to help.
AstraZeneca, the company that makes Faslodex, offers the AZ Cancer Support Network, which can help you learn about prescription programs. In the United States, call 1-866-992-9276, or visit the AstraZeneca patient prescription assistance programs page.
Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003
Learn more about our commitment to your privacy
© 2009 Breastcancer.org - All rights reserved.
Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.